Loss of ZNF148 enhances insulin secretion in human pancreatic β cells

Insulin secretion from pancreatic β cells is essential to the maintenance of glucose homeostasis. Defects in this process result in diabetes. Identifying genetic regulators that impair insulin secretion is crucial for the identification of novel therapeutic targets. Here, we show that reduction of Z...

Full description

Bibliographic Details
Main Authors: Eleonora de Klerk, Yini Xiao, Christopher H. Emfinger, Mark P. Keller, David I. Berrios, Valentina Loconte, Axel A. Ekman, Kate L. White, Rebecca L. Cardone, Richard G. Kibbey, Alan D. Attie, Matthias Hebrok
Format: Article
Language:English
Published: American Society for Clinical investigation 2023-06-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.157572
_version_ 1827767974890569728
author Eleonora de Klerk
Yini Xiao
Christopher H. Emfinger
Mark P. Keller
David I. Berrios
Valentina Loconte
Axel A. Ekman
Kate L. White
Rebecca L. Cardone
Richard G. Kibbey
Alan D. Attie
Matthias Hebrok
author_facet Eleonora de Klerk
Yini Xiao
Christopher H. Emfinger
Mark P. Keller
David I. Berrios
Valentina Loconte
Axel A. Ekman
Kate L. White
Rebecca L. Cardone
Richard G. Kibbey
Alan D. Attie
Matthias Hebrok
author_sort Eleonora de Klerk
collection DOAJ
description Insulin secretion from pancreatic β cells is essential to the maintenance of glucose homeostasis. Defects in this process result in diabetes. Identifying genetic regulators that impair insulin secretion is crucial for the identification of novel therapeutic targets. Here, we show that reduction of ZNF148 in human islets, and its deletion in stem cell–derived β cells (SC–β cells), enhances insulin secretion. Transcriptomics of ZNF148-deficient SC–β cells identifies increased expression of annexin and S100 genes whose proteins form tetrameric complexes involved in regulation of insulin vesicle trafficking and exocytosis. ZNF148 in SC–β cells prevents translocation of annexin A2 from the nucleus to its functional place at the cell membrane via direct repression of S100A16 expression. These findings point to ZNF148 as a regulator of annexin-S100 complexes in human β cells and suggest that suppression of ZNF148 may provide a novel therapeutic strategy to enhance insulin secretion.
first_indexed 2024-03-11T12:05:57Z
format Article
id doaj.art-b4b5dbeb38934b90baccd9d13f8ca114
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-03-11T12:05:57Z
publishDate 2023-06-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-b4b5dbeb38934b90baccd9d13f8ca1142023-11-07T16:25:42ZengAmerican Society for Clinical investigationJCI Insight2379-37082023-06-01811Loss of ZNF148 enhances insulin secretion in human pancreatic β cellsEleonora de KlerkYini XiaoChristopher H. EmfingerMark P. KellerDavid I. BerriosValentina LoconteAxel A. EkmanKate L. WhiteRebecca L. CardoneRichard G. KibbeyAlan D. AttieMatthias HebrokInsulin secretion from pancreatic β cells is essential to the maintenance of glucose homeostasis. Defects in this process result in diabetes. Identifying genetic regulators that impair insulin secretion is crucial for the identification of novel therapeutic targets. Here, we show that reduction of ZNF148 in human islets, and its deletion in stem cell–derived β cells (SC–β cells), enhances insulin secretion. Transcriptomics of ZNF148-deficient SC–β cells identifies increased expression of annexin and S100 genes whose proteins form tetrameric complexes involved in regulation of insulin vesicle trafficking and exocytosis. ZNF148 in SC–β cells prevents translocation of annexin A2 from the nucleus to its functional place at the cell membrane via direct repression of S100A16 expression. These findings point to ZNF148 as a regulator of annexin-S100 complexes in human β cells and suggest that suppression of ZNF148 may provide a novel therapeutic strategy to enhance insulin secretion.https://doi.org/10.1172/jci.insight.157572MetabolismStem cells
spellingShingle Eleonora de Klerk
Yini Xiao
Christopher H. Emfinger
Mark P. Keller
David I. Berrios
Valentina Loconte
Axel A. Ekman
Kate L. White
Rebecca L. Cardone
Richard G. Kibbey
Alan D. Attie
Matthias Hebrok
Loss of ZNF148 enhances insulin secretion in human pancreatic β cells
JCI Insight
Metabolism
Stem cells
title Loss of ZNF148 enhances insulin secretion in human pancreatic β cells
title_full Loss of ZNF148 enhances insulin secretion in human pancreatic β cells
title_fullStr Loss of ZNF148 enhances insulin secretion in human pancreatic β cells
title_full_unstemmed Loss of ZNF148 enhances insulin secretion in human pancreatic β cells
title_short Loss of ZNF148 enhances insulin secretion in human pancreatic β cells
title_sort loss of znf148 enhances insulin secretion in human pancreatic β cells
topic Metabolism
Stem cells
url https://doi.org/10.1172/jci.insight.157572
work_keys_str_mv AT eleonoradeklerk lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT yinixiao lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT christopherhemfinger lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT markpkeller lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT davidiberrios lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT valentinaloconte lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT axelaekman lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT katelwhite lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT rebeccalcardone lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT richardgkibbey lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT alandattie lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells
AT matthiashebrok lossofznf148enhancesinsulinsecretioninhumanpancreaticbcells